3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
2
Thoracic
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Triple Negative Breast Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasms
1
Mesothelioma, Malignant
1
Mesothelioma
1
Kidney Neoplasms
1
Colorectal Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Surveys and Questionnaires
79
Blood Specimen Collection
67
palbociclib
40
Trastuzumab
34
Drug Therapy
30
Letrozole
29
Anastrozole
27
Radiotherapy
26
Immunohistochemistry
26
Mastectomy, Segmental
22
Amplified Fragment Length Polymorphism Analysis
22
Fulvestrant
21
Biopsy
21
exemestane
20
Tamoxifen
20
Interviews as Topic
20
Gene Expression Profiling
20
Magnetic Resonance Spectroscopy
19
ribociclib
18
Specimen Handling
18
Mastectomy
18
Neoadjuvant Therapy
17
Paclitaxel
16
High-Energy Shock Waves
16
Capecitabine
16
trastuzumab deruxtecan
15
Mammography
15
Psychiatric Rehabilitation
14
Polymerase Chain Reaction
13
Observation
13
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Blood Component Removal
×
Breast
×
Clear all
NCT04981119
2026-06-02
BASECAMP-1
A2 Biotherapeutics Inc.
Recruiting
200 enrolled